Short answer
ACCURAY INC (ARAY) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Series A Preferred Stock issued in a private placement to Investors.
ACCURAY INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.02 · Unregistered Sales of Equity Securities
- Series A Preferred Stock issued in a private placement to Investors
- Transaction relied on Securities Act Section 4(a)(2) exemption, avoiding registered public offering requirements
- Accredited-investor representations supported the exemption, limiting immediate public-market participation
- Details of the preferred stock issuance are incorporated from Item 3.03, requiring review for investor rights and dilution implications
Item 3.03 · Material Modification to Rights of Security Holders
- $55.0M Series A preferred issuance: $15.0M cash plus conversion of $40.0M existing investor debt
- 8% annual preferred dividend, compounding quarterly and payable in cash or added to stated value
- Senior liquidation preference, initially $1,000 per share plus unpaid dividends, ahead of common stock
- Holder conversion option at $20.00 per common share, representing 2.75M initial potential shares
- Investor consent rights constrain senior securities, board changes and amendments affecting preferred-holder protections
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- 1-for-40 reverse split effective November 9, 2026, raising ARAY’s per-share trading price and reducing shares outstanding proportionally
- Nasdaq Capital Market trading continued under ARAY with new CUSIP 004397 303
- Authorized common shares ultimately reduced from 400,000,000 to 10,000,000 after the split
- Total authorized capital stock reduced from 405,000,000 to 15,000,000, including 5,000,000 preferred shares
- Fractional shares paid in cash, creating potential small cash-outs for affected holders
Item 7.01 · Regulation FD Disclosure
- Cancellation extinguished warrants covering approximately 27.6 million shares, removing substantial potential dilution
- Eliminated warrant exercise prices ranging from $1.25 to $1.68 per share
- Press release announced authorized-share increase, reverse stock split, and Series A Preferred Stock issuance
- Investors should assess the preferred issuance and capital-structure changes alongside reduced warrant overhang
Item EX-99.1 · Exhibit EX-99.1
- TCW exchanged $40 million of term-loan principal for convertible preferred stock, materially reducing Accuray’s debt burden
- TCW’s $15 million cash investment converted into additional convertible preferred shares, providing balance-sheet capital
- Financial covenants waived through December 31, 2027, delaying the first covenant test until March 31, 2028
- Up to $5 million delayed-draw term loan available, subject to conditions, adding potential liquidity
- TCW gains two of seven board seats, while the 1-for-40 reverse split took effect November 9, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCURAY INC 8-K filings
Get the next ARAY 8-K as it lands
Follow ARAY for push alerts, or ask the research agent what this filing means.